NCI Open Access Pilot Program for Data and Results from Cancer Moonshot℠ Research

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Consistent with the data-sharing goals of the Cancer Moonshot, NCI is establishing a data sharing pilot program that supports open access for all research results and underlying data of projects that are funded as part of the Cancer Moonshot. This approach implements recommendations - for researchers, clinicians, and patients to collaborate in sharing their collective data and knowledge about cancer - made by the Enhanced Data Sharing working group of the Blue Ribbon Panel, formed in April 2016 under the auspices of the National Cancer Advisory Board. NCI will give competitive preference and funding priority to applications with a data sharing plan that is aligned with this preference. In addition, the data sharing plan will become a term and condition of award. NCI expects awardees to include anticipated publication charges in the budget plan of their application.

Cancer Moonshot Open Access Policy

One of the current obstacles to sharing cancer research data is the set of restrictions that usually accompanies publishing of research results. Publications often require research results/publications to be available only through a pay-for-access model, and the data associated with the research may be embargoed for six or twelve months. This delay in the availability of the research results and the data behind it prevents dissemination of new knowledge, impedes reproducibility, and slows the ability of researchers to build upon research to make new discoveries.

Based on the provisions outlined in the 21st Century Cures Act, NCI has established a data sharing strategy that requires open access to all research results and underlying data for projects that are funded as part of the Cancer Moonshot. NCI expects awardees to follow this.

Awardees with published, peer-reviewed articles resulting from research funded through the Beau Biden Cancer Moonshot will ensure that the articles are made available in PubMed Central in accordance as follows:

  • Publications will be deposited in PubMed Central with proper tagging of metadata to ensure online discoverability and accessibility.
  • All publications shall be published in the Creative Commons Attribution 4.0 Generic License (CC BY 4.0) or an equivalent license. This will permit all users of the publication to copy and redistribute the material in any medium or format and transform and build upon the material for any purpose without further permission or fees being required.
  • All publications will be available immediately upon their publication, without any embargo period.
  • Awardees will ensure that an electronic copy of their final peer-reviewed manuscript is deposited in PubMed Central within four weeks of its acceptance for journal publication.
  • NCI support must be acknowledged in every article reporting findings from research funded in whole or part by the Beau Biden Cancer Moonshot℠ section of the 21st Century Cures Act, consistent with NIH Guidelines. The acknowledgement statement must include the applicable grant or contract number, which will enable NCI to link the published outputs of NCI-funded research to the support NCI has provided.
  • Data underlying the published research results should also be made broadly available through an appropriate data repository such as the Genomic Data Commons, dbGaP, TCIA, FigShare, etc. Data will be shared at the time of publication and made immediately accessible and released under the Creative Commons Attribution 4.0 Generic License (CC BY 4.0) or an equivalent license and deposited in PubMed Central. Licenses that retain intellectual property for commercialization but retain the features of open access [unembargoed, no fee access] for non-commercial use are encouraged. Data that include PII and other sensitive information should also be immediately released with no fee for access, but may require controlled access. Controlled access repositories should use policies similar to dbGaP, where the data access committee is independent of the data contributors and the data requesters and there are no financial incentives for limiting access to datasets.

Open Access Fees for Published Articles

NCI expects awardees to include anticipated publication charges in the budget plan of their application. These charges include article or author fees charged by open access journals, Creative Commons license fees, or similar fees that ensure free, public, open (or controlled) access to an awardee’s article immediately upon its publication.

  • Posted: June 7, 2017

Most text on the National Cancer Institute website may be reproduced or reused freely. The National Cancer Institute should be credited as the source. Please note that blog posts that are written by individuals from outside the government may be owned by the writer, and graphics may be owned by their creator. In such cases, it is necessary to contact the writer, artist, or publisher to obtain permission for reuse.

We welcome your comments on this post. All comments must follow our comment policy.